Two projects have received funding from OHSU's 2022 Biomedical Innovation Program, both in the Device, Diagnostic, Software track. The funding program, which is a collaboration between the Oregon...
Erik Tucker, Ph.D., research assistant professor in the Department of Biomedical Engineering, OHSU School of Medicine, has been named a 2022 Fellow of the National Academy of Inventors (NAI). NAI...
OHSU startup company Autobahn Therapeutics reached a major milestone in November with the initiation of a Phase 1 clinical trial of a treatment for major depressive disorder....
OHSU Innovates has announced winners of the 2022 Research and Innovation Awards. These five members of the OHSU community are recognized for significant contributions to innovation and...
"Broadening the bar to include innovation and entrepreneurial activities is a strategy that can be broadly applicable to recognize the many evolving dimensions along which faculty create societal...
Projects aim to provide novel improvements to screening for diabetic retinopathy, optimizing prosthetic fit via smartphone, and imaging metabolic activity. Three projects have been named recipients...
Do you have an idea for an innovative technology but don’t know where to start? Biomedical Innovation Commercialization Readiness Program (BIP Corp) is a five-week experiential course designed to...
Childbirth outcomes, vascular disease, headaches and magnetic resonance imaging — these are targets of 2021 Biomedical Innovation Program funding in the device and diagnostic track. This...
OHSU is changing its policies for employees who are involved in startup companies to align more with national peers. An OHSU Startup Company is defined as a company that meets one or more of the...
UPDATE: On June 30, 2020, the FDA approved the use of triheptanoin to treat pediatric and adult patients with molecularly confirmed long-chain fatty acid oxidation disorders (LC-FAOD). See...